SENSICARDIAC vs iPredict Eye Screening
AI Verdict
Choose SENSICARDIAC if…
Choose SENSICARDIAC if your practice requires an advanced, AI-driven solution for real-time heart murmur detection and classification, particularly in a remote or telehealth setting. It is ideal for physicians aiming to quickly differentiate between pathological and physiological murmurs, thereby streamlining cardiac care pathways and reducing unnecessary specialist referrals.
View SENSICARDIAC →Choose iPredict Eye Screening if…
Choose iPredict Eye Screening if your clinic needs a comprehensive, AI-powered platform for early detection of multiple retinal diseases like AMD, Diabetic Retinopathy, and Glaucoma, especially in a primary care setting. This tool is also beneficial for identifying patients at risk for systemic conditions such as stroke and heart attack, integrating seamlessly with existing EHR and telemedicine services.
View iPredict Eye Screening →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | SENSICARDIAC | iPredict Eye Screening |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser. | Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps. |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
SENSICARDIACSENSICARDIAC (Tool A) offers a 'guided auscultation process' and integrates with familiar electronic stethoscopes, which can streamline the workflow and reduce the learning curve for clinicians. While iPredict Eye Screening (Tool B) emphasizes ease of operation and an advanced touchscreen, the guided nature of Tool A's diagnostic procedure provides a slight edge in ensuring consistent and correct usage.
Clinical Value
iPredict Eye ScreeningiPredict Eye Screening (Tool B) offers broader clinical value by screening for multiple critical eye conditions (Diabetic Retinopathy, AMD, Glaucoma) and, notably, providing risk prediction for systemic diseases like stroke and heart attack. SENSICARDIAC (Tool A) focuses on heart murmur detection and classification, which is valuable but more specialized compared to Tool B's multi-faceted approach and systemic risk assessment.
Pricing & Value
iPredict Eye ScreeningiPredict Eye Screening (Tool B) provides greater transparency in its pricing model, offering an estimated per-patient screening cost ($10-$20). This allows healthcare providers to more effectively assess the value proposition and integrate it into their financial planning. SENSICARDIAC (Tool A) only states 'contact for pricing,' making it difficult to evaluate its cost-effectiveness upfront.
Enterprise Readiness
SENSICARDIACSENSICARDIAC (Tool A) explicitly states that it 'has_baa': 'yes', which is a critical requirement for healthcare organizations to ensure HIPAA compliance when engaging with third-party vendors. While iPredict Eye Screening (Tool B) mentions EHR integration and HIPAA compliance, the absence of an explicit BAA statement in its specifications presents a potential hurdle for enterprise adoption.
Innovation
iPredict Eye ScreeningiPredict Eye Screening (Tool B) demonstrates greater innovation by not only screening for multiple ocular diseases but also leveraging retinal imaging to predict systemic health risks like stroke and heart attack. This broader application of AI in preventive care, extending beyond the primary diagnostic area, represents a more novel and impactful approach compared to SENSICARDIAC's (Tool A) enhancement of a specific diagnostic procedure.
Support & Docs
TieBased on the provided structured facts and available public web information, neither SENSICARDIAC (Tool A) nor iPredict Eye Screening (Tool B) explicitly details their specific support channels, documentation availability, or service level agreements. Without this information, it is not possible to distinguish between the two tools on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | SENSICARDIAC | iPredict Eye Screening |
|---|---|---|
| Name | SENSICARDIAC | iPredict Eye Screening |
| Company | DIACOUSTIC MEDICAL (PTY) | iHealthScreen |
| Description | AI-powered, cloud-based heart murmur detection service that integrates with electronic stethoscopes to classify murmurs as pathological or physiological, aiding physicians in diagnosis and reducing unnecessary referrals. | FDA-cleared AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, alongside screening for Diabetic Retinopathy (DR) and Glaucoma. The platform also provides risk prediction for systemic diseases like stroke and heart attack, integrating with EHR and telemedicine services. |
| Primary Focus | Heart murmur detection and classification | Retinal disease screening (DR, AMD, Glaucoma) and systemic disease risk prediction |
| Key Features (Examples) | AI-powered heart murmur detection, Cloud-based service, Integration with electronic stethoscopes (e.g., 3M Littmannu00ae 3200), Real-time analysis | AI-Based Screening for Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma, Electronic Health Record (EHR) Solutions, Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients, Fast results: test completed in less than 5 minutes, report in under 60 seconds |
Videos
Demos, reviews, and walkthroughs featuring SENSICARDIAC and iPredict Eye Screening.